Pill to treat Covid-19 cuts the risk of death by half, says Merck, which will seek its emergency authorization
A pill has cut the risk of hospitalization or death from Covid-19 by half in a study, Merck and Ridgeback Biotherapeutics said Friday. It would become the first oral medicine that fights viral infection for Covid-19 if approved by the US Food and Drug Administration for...